Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation

Xiao-Yan Qi1, Faezeh Vahdati Hassani1, Dennis Hoffmann2

  • 1Medicine, Montreal Heart Institute, Université de Montréal, Canada (X.-Y.Q., F.V.H., J.X., F.X., L.R.V., D.D., S.N.).

Circulation Research
|December 30, 2020
PubMed
Abstract

Insights

Atrial fibrillation (AF) increases nuclear calcium levels in heart cells by upregulating IP3R1, driven by miR-26a. This impacts CaMKII-HDAC4 signaling and reduces L-type calcium currents, contributing to AF mechanisms.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Arrhythmia Mechanisms

Background:

  • Atrial fibrillation (AF) is the most common arrhythmia, yet its underlying mechanisms remain unclear.
  • Nuclear calcium (Ca2+) dynamics are critical for gene expression but poorly understood in AF.
  • The role of nucleoplasmic Ca2+ and CaMKII signaling in AF pathogenesis requires elucidation.

Purpose of the Study:

  • To investigate how AF affects atrial cardiomyocyte nuclear Ca2+ levels ([Ca2+]Nuc) and CaMKII signaling pathways.
  • To identify the molecular regulators involved in AF-induced nuclear Ca2+ dysregulation.
  • To explore the functional consequences of these changes on cardiomyocyte function.

Main Methods:

  • Isolated atrial cardiomyocytes from control and AF dogs were used for Ca2+ measurements via confocal microscopy.
  • Inositol-trisphosphate receptor (IP3R) stimulation and blockade were employed to assess Ca2+ flux.
  • Protein expression and phosphorylation of IP3R1, CaMKII, and HDAC4 were analyzed using immunohistochemistry and immunoblotting.
  • Experiments included cardiomyocyte tachypacing and microRNA analysis (miR-26a).

Main Results:

  • AF increased both diastolic and resting nuclear Ca2+ ([Ca2+]Nuc) in atrial cardiomyocytes.
  • AF upregulated nuclear IP3R1 and phosphorylated CaMKII, while decreasing the nuclear/cytosolic ratio of HDAC4.
  • IP3R1 upregulation, driven by decreased miR-26a, was identified as a key mechanism.
  • These changes mimicked AF-induced decreases in L-type calcium current.

Conclusions:

  • AF elevates atrial cardiomyocyte nuclear Ca2+ via IP3R1 upregulation, involving miR-26a.
  • This leads to altered IP3R1-CaMKII-HDAC4 signaling, impacting cardiomyocyte function.
  • The findings provide novel insights into AF mechanisms and potential therapeutic targets.

Related Concept Videos

Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.7K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.6K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.3K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.6K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.2K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.2K